Can-Fite BioPharma Rings The Opening Bell at NYSE

Can-Fite Biopharma Ltd - $CANF |


On Dec. 5, Can-Fite BioPharma (CANF)  celebrated rang the Opening Bell at the New York Stock Exchange to celebrate the Petach Tikva, Israel-based company's recent listing on the NYSE MKT. CEO Dr. Pnina Fishman was joined by key members of the company's management team and their guests for the momentous ceremony. Can-Fite is a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases. Be sure to read Equities.com's interview with Dr. Fishman here to learn more about Can-Fite's strategic focus and goals going forward.

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel) 1.92 0.04 2.13 144,669
BMQCF Bank of Montreal Non Cumulative 5-Year Rate Reset n/a n/a n/a 0

Comments

Emerging Growth

Taranis Resources Inc.

Taranis Resources Inc is an exploration stage company. The Company along with its subsidiaries is engaged in the acquisition and exploration of mineral properties. Its projects include Thor Property in…

Private Markets

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…

Mesa-Marshall 2 Well Project

MESA Resources ("MESA") is sponsoring the development of the two well direct drilling project -- "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development of…